| Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer (NCT00004232) | Northwestern University | 1999-10-01 |
| Busulfan and Cyclophosphamide Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome (NCT00004896) | Northwestern University | 1999-10-01 |
| Stem Cell Transplantation in Treating Patients With Hematologic Cancer (NCT00004904) | Northwestern University | 1999-10-01 |
| Bone Marrow Transplantation in Treating Patients With Hematologic Cancer (NCT00005804) | Fred Hutchinson Cancer Center | 1999-10-01 |
| Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer (NCT00290628) | Masonic Cancer Center, University of Minnesota | 1999-10-01 |
| Chemotherapy Plus Bone Marrow Transplantation and Filgrastim in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome (NCT00004899) | Northwestern University | 1999-10-01 |
| Sodium Salicylate in Treating Patients With Advanced Myelodysplastic Syndrome, Acute Myelogenous Leukemia, or Chronic Lymphocytic Leukemia (NCT00004245) | Memorial Sloan Kettering Cancer Center | 1999-08-01 |
| Perifosine in Treating Patients With Refractory Solid Tumors or Hematologic Cancer (NCT00019656) | National Cancer Institute (NCI) | 1999-08-01 |
| 6-Hydroxymethylacylfulvene in Treating Patients With Refractory Myelodysplastic Syndrome, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Blastic Phase Chronic Myelogenous Leukemia (NCT00003997) | National Cancer Institute (NCI) | 1999-07-01 |
| Arsenic Trioxide With or Without Tretinoin in Treating Patients With Hematologic Cancer That Has Not Responded to Previous Therapy (NCT00006220) | Washington University School of Medicine | 1999-06-01 |
| Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome (NCT00003593) | Children's Oncology Group | 1999-06-01 |
| Chemotherapy in Treating Patients Who Have Hematologic Cancer (NCT00004047) | Daiichi Sankyo | 1999-06-01 |
| Vaccine Therapy in Treating Patients With Myelodysplastic Syndrome (NCT00003959) | Memorial Sloan Kettering Cancer Center | 1999-06-01 |
| Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer (NCT00005092) | M.D. Anderson Cancer Center | 1999-05-28 |
| Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic Syndrome (NCT00003961) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1999-04-01 |
| S9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer (NCT00919425) | SWOG Cancer Research Network | 1999-04-01 |
| Topotecan in Treating Patients With Myelodysplastic Syndrome (NCT00003675) | Alliance for Clinical Trials in Oncology | 1999-03-01 |
| Monoclonal Antibody Therapy in Treating Patients With Primary Myelodysplastic Syndrome (NCT00003984) | European Organisation for Research and Treatment of Cancer - EORTC | 1999-02-01 |
| Combination Chemotherapy in Treating Patients With Myelodysplastic Syndrome (NCT00003827) | ALZA | 1999-01-01 |
| Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer (NCT00296023) | University of California, San Francisco | 1999-01-01 |
| Dolastatin 10 in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia (NCT00003693) | M.D. Anderson Cancer Center | 1998-12-18 |
| Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome (NCT00005823) | Leukemia Research Fund | 1998-12-01 |
| Cellular Adoptive Immunotherapy in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndromes That Relapsed After Donor Stem Cell Transplant (NCT00107354) | Fred Hutchinson Cancer Center | 1998-12-01 |
| Genetic Study of Children With Soft Tissue Sarcoma or Rhabdomyosarcoma (NCT00003793) | Children's Oncology Group | 1998-12-01 |
| Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease (NCT00003913) | Fred Hutchinson Cancer Center | 1998-12-01 |
| A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome (NCT00001839) | National Institutes of Health Clinical Center (CC) | 1998-12-01 |
| Chemotherapy Plus Biological Therapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer (NCT00004145) | University of Chicago | 1998-11-01 |
| Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer (NCT00003816) | Roswell Park Cancer Institute | 1998-10-19 |
| Fludarabine, Carboplatin, and Topotecan in Treating Patients With Relapsed/Refractory Acute Leukemia or Advanced Myelodysplastic Syndrome (NCT00005593) | Case Comprehensive Cancer Center | 1998-09-01 |
| Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer (NCT00003396) | University of Maryland, Baltimore | 1998-09-01 |
| Amifostine Plus Topotecan in Treating Patients With Myelodysplastic Syndrome (NCT00003415) | University of Arizona | 1998-09-01 |
| Bone Marrow Transplantation in Treating Patients With Hematologic Cancer (NCT00003398) | University of Maryland, Baltimore | 1998-09-01 |
| Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancers (NCT00003572) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1998-08-01 |
| Amifostine With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome (NCT00003681) | European Organisation for Research and Treatment of Cancer - EORTC | 1998-08-01 |
| Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation (NCT00003887) | Fred Hutchinson Cancer Center | 1998-08-01 |
| Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer (NCT00003451) | National Cancer Institute (NCI) | 1998-08-01 |
| Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases (NCT00003662) | Roswell Park Cancer Institute | 1998-08-01 |
| Treatment for Chronic Pain in Patients With Advanced Cancer (NCT00003687) | NCIC Clinical Trials Group | 1998-06-11 |
| Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer (NCT00003661) | Roswell Park Cancer Institute | 1998-06-01 |
| HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological Malignancies (NCT00001748) | National Heart, Lung, and Blood Institute (NHLBI) | 1998-06-01 |
| Bryostatin 1 in Treating Patients With Myelodysplastic Syndrome (NCT00003171) | Barbara Ann Karmanos Cancer Institute | 1998-05-01 |
| Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer (NCT00003408) | Cancer Treatment Centers of America | 1998-04-01 |
| Combination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic Disorders (NCT00008307) | Herbert Irving Comprehensive Cancer Center | 1998-04-01 |
| Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer (NCT00003960) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1998-04-01 |
| Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes (NCT00003138) | Eastern Cooperative Oncology Group | 1998-03-04 |
| Combination Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia (NCT00003602) | Riverside Haematology Group | 1998-03-01 |
| Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia (NCT00003619) | Drexel University College of Medicine | 1998-02-01 |
| Combination Chemotherapy in Treating Patients With Advanced Cancer (NCT00003331) | NYU Langone Health | 1998-01-01 |
| Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer (NCT00003335) | Case Comprehensive Cancer Center | 1998-01-01 |
| Combination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic Cancer (NCT00003243) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1998-01-01 |
| Pilot Study Of Unrelated UCB Transplant for Non-Malignant Hematologic Conditions (NCT00003336) | Case Comprehensive Cancer Center | 1998-01-01 |
| Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer (NCT00003082) | University of Arizona | 1997-12-01 |
| Arsenic Trioxide in Treating Patients With Recurrent or Refractory Acute Leukemia, Chronic Myeloide Leukemia, Myelodysplasia, Lymphoma, or Myeloma (NCT00003885) | Our Lady of Mercy Medical Center | 1997-11-01 |
| Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer (NCT00004036) | The Cleveland Clinic | 1997-11-01 |
| Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors (NCT00003107) | Indiana University | 1997-10-01 |
| Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer (NCT00003270) | Roswell Park Cancer Institute | 1997-09-04 |
| Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation (NCT00005641) | H. Lee Moffitt Cancer Center and Research Institute | 1997-09-01 |
| Amifostine in Treating Patients With Advanced Myelodysplastic Syndrome (NCT00003123) | Providence Hospital | 1997-08-01 |
| Decitabine in Treating Patients With Melanoma or Other Advanced Cancer (NCT00002980) | California Cancer Consortium | 1997-05-01 |
| Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome (NCT00002989) | European Organisation for Research and Treatment of Cancer - EORTC | 1997-03-01 |
| Umbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia (NCT00008164) | Herbert Irving Comprehensive Cancer Center | 1997-01-01 |
| Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia (NCT00002926) | European Organisation for Research and Treatment of Cancer - EORTC | 1996-12-01 |
| Monoclonal Antibody Therapy in Treating Patients With Myelodysplastic Syndrome or Relapsed or Refractory Acute Myeloid Leukemia or Chronic Myelogenous Leukemia (NCT00002890) | Memorial Sloan Kettering Cancer Center | 1996-10-01 |
| Cord Blood Stem Cell Transplantation Study (COBLT) (NCT00000603) | National Heart, Lung, and Blood Institute (NHLBI) | 1996-09-01 |
| Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic Syndrome (NCT00002800) | Memorial Sloan Kettering Cancer Center | 1996-07-01 |
| Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer (NCT00008216) | Columbia University | 1996-07-01 |
| Bone Marrow Transplantation in Treating Patients With Severe Aplastic Anemia or Rejection of Previous Bone Marrow Transplant (NCT00005852) | H. Lee Moffitt Cancer Center and Research Institute | 1996-06-01 |
| Donor Bone Marrow Transplant in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders (NCT00005622) | H. Lee Moffitt Cancer Center and Research Institute | 1996-05-01 |
| Quality of Life of Adult Cancer Survivors Who Have Undergone a Previous Bone Marrow or Peripheral Stem Cell Transplant for a Childhood Hematologic Cancer (NCT00126477) | Fred Hutchinson Cancer Center | 1996-03-01 |
| Prevention of Graft-Versus-Host Disease in Patients With Hematologic Malignancies Who Are Receiving a Bone Marrow Transplant (NCT00002790) | Fred Hutchinson Cancer Center | 1996-03-01 |
| Interleukin-2 in Treating Patients With Myelodysplastic Syndrome (NCT00002746) | University of Washington | 1996-01-01 |
| Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer (NCT00002742) | Aronex Pharmaceuticals | 1996-01-01 |
| T-cell Depleted Bone Marrow and G-CSF Stimulated Peripheral Stem Cell Transplantation From Related Donors in Treating Patients With Leukemia, Lymphoblastic Lymphoma, Myelodysplastic Syndrome, or Aplastic Anemia (NCT00002718) | Memorial Sloan Kettering Cancer Center | 1995-11-01 |
| Decitabine and Peripheral Stem Cell Transplantation in Treating Patients Who Have Relapsed Following Bone Marrow Transplantation for Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia (NCT00002832) | M.D. Anderson Cancer Center | 1995-08-01 |
| Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic Lymphoma (NCT00003187) | Virginia Commonwealth University | 1995-05-01 |
| Detection of Residual Disease in Children Receiving Therapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome (NCT00003790) | Children's Oncology Group | 1995-02-01 |
| Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous Leukemia (NCT00002833) | M.D. Anderson Cancer Center | 1994-10-01 |
| T-Cell Depletion in Unrelated Donor Marrow Transplantation (NCT00000591) | National Heart, Lung, and Blood Institute (NHLBI) | 1993-11-01 |
| Bone Marrow Transplant in Treating Patients With Hematologic Cancers (NCT00005797) | H. Lee Moffitt Cancer Center and Research Institute | 1993-03-01 |
| Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome (NCT00002517) | European Organisation for Research and Treatment of Cancer - EORTC | 1993-03-01 |
| Sibling and Unrelated Donor Hematopoietic Cell Transplant in Hematologic Malignancies (NCT00186342) | Stanford University | 1992-09-01 |
| Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome (NCT00002502) | Memorial Sloan Kettering Cancer Center | 1992-07-01 |
| S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers (NCT00996047) | SWOG Cancer Research Network | 1991-07-01 |
| Chemotherapy and Bone Marrow Transplantation in Treating Patients Acute Myeloid With Leukemia or Myelodysplastic Syndrome (NCT00002547) | Barbara Ann Karmanos Cancer Institute | 1987-08-01 |
| Expanded Access for Treatment With Imetelstat (NCT05937568) | Geron Corporation | |
| Expanded Access Program With Pevonedistat (Given With Azacitidine) for Adults With Higher-risk Myelodysplastic Syndromes (NCT04484363) | Takeda | |
| Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies (NCT01101412) | M.D. Anderson Cancer Center | |
| Study of Clofarabine in Combination With Low Dose Cytarabine to Treat Myelodysplastic Syndromes (NCT01302106) | Fondazione Italiana Sindromi Mielodisplastiche-ETS | |
| A Phase 2 Study to Evaluate the Safety and Effectiveness of Once Weekly or Once Every Two Week Dosing of Epoetin Alfa in Anemic Patients With Low- or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) (NCT00446602) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| OTI-010 for Graft-Versus-Host Disease Prophylaxis in Treating Patients Who Are Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic Malignancies (NCT00081055) | Mesoblast International Sàrl | |
| Expanded Access Program (EAP) for Galinpepimut-S (GPS) in Patients Diagnosed With AML or MDS (NCT05593185) | Sellas Life Sciences Group | |
| Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Hematologic Cancer (NCT00004114) | Jonsson Comprehensive Cancer Center | |